Outlines

Channelopathy and Essential Needs to Search in Venomous Animals for Toxins

Author(s):
Hossein VatanpourHossein Vatanpour1,*
1Associate Professor of Toxicology & Pharmacology, School of Pharmacy, Shahid Beheshti University, M. C., Tehran, Iran
*Corresponding Author: Associate Professor of Toxicology & Pharmacology, School of Pharmacy, Shahid Beheshti University, M. C., Tehran, Iran. Email:[email protected]

IJ Pharmaceutical Research:Vol. 8, issue 1; 1-1
Published online:Nov 20, 2010
Article type:Editorial
Received:Jan 01, 2009
Accepted:Jan 01, 2009
How to Cite:Vatanpour H. Channelopathy and Essential Needs to Search in Venomous Animals for Toxins. Iran J Pharm Res. 2022;8(1):e128608. doi: https://doi.org/10.22037/ijpr.2010.781

Fulltext

Channelopathy as a new word in medical vocabulary describes those human diseases that results from defects in ion channel function. Ion channels as a pathway for the movement of ions across cell membranes play essential roles in the physiology and pathophysiology of all cells and it is therefore not very surprising that an ever increasing number of human diseases have been found to be caused by defective ion channel function that we may need to search for medicine to treat them. To understand this we need to know at least a basic understanding of the genetics, molecular structure, biophysical properties and physiological role of ion channels. Further more, ion channels play an important role in transmitting information in the nervous system. Na+ and K+ channels are involved in action potentials, and at nerve endings, channels selective for Na+, K+ and Ca++ ions are involved in action potentials and the release of neurotransmitters.

Considering this point, venoms or poisons and toxins which are pure fractions isolated from each of them could be used as pharmacological tools to identify and study physiological role of ion channels, as well as introducing the different types or sub-type of ion channels activity in cell membranes. Nevertheless, they may play a medicinal role to treat different channel related diseases.

In the past, biophysical and pharmacological studies of some of the post-synaptic receptors and ion channels have been aided by the use of potent and selective toxins, e.g. α-bungarotoxin to isolate and characterize the nicotinic acetylcholine receptor-ion channels complex. Similarly, tetrodotoxin and saxitoxin have been fundamental to the characterization of Na+ channels in neurons. Until fairly recently, however, characterization of neuronal K+ and Ca2+ channels has been restricted by a lack of suitable selective and high affinity probes. Characterization of these ion channels and ionic currents at nerve terminals is particularly important, because, by regulating the frequency and duration of action potentials, the K+ and Ca2+ channels can regulate nerve terminal excitability and transmitter release. Because Na+ channel-mediated action potentials are essential to the functioning of the nervous system, it is perhaps not surprising that many toxins exist, which act at the Na+ channel. In contrast to Na+ channels, many types of K+ channels exist in neurons. There are three main classes based on the kind of stimulus required to convert them from the closed to the open configuration. They include voltage- dependent K+ channels, K+ channel regulated by intracellular “messengers” like Ca2+ and K+ channels which can be activated by neurotransmitters, e.g. serotonin or acetylcholine. Besides, we should never forget recent reports related to the effects of the bee venom on the treatment of rheumatoid arthritis or Multiple Sclerosis. The variety of venomous animals and their subtypes from snakes, scorpions, spiders in earth, and bees in air to puffer fish and sea anemonia in oceans, open a large research area to distinguish the effects of venom and toxins on human cell, which may help us to obtain a novel drug to treat different diseases related to channel functions.

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Mar
2020
Archives of Clinical Infectious Diseases

A Brief Review on Biting/Stinging of Animals and Its Risk of Infection

Rouhullah Dehghani,
Hamid Kassiri,
Mousa Dehghani

Dehghani R, Kassiri H, Dehghani M. A Brief Review on Biting/Stinging of Animals and Its Risk of Infection. Arch Clin Infect Dis. 2020;15(1):e97499. doi: https://doi.org/10.5812/archcid.97499

4
Aug
2025
Jundishapur J Nat Pharm Prod

Promising Venom-derived Peptides as Innovative Health Solutions for Treating the Metabolic Disorders: A Policy Brief

Masoumeh Baradaran

Baradaran M. Promising Venom-derived Peptides as Innovative Health Solutions for Treating the Metabolic Disorders: A Policy Brief. Jundishapur J Nat Pharm Prod. 2025;20(3):e163296. doi: https://doi.org/10.5812/jjnpp-163296

14
Feb
2023
Jundishapur J Nat Pharm Prod

Current Status of Peptide Medications and the Position of Active Therapeutic Peptides with Scorpion Venom Origin

Masoumeh Baradaran

Baradaran M. Current Status of Peptide Medications and the Position of Active Therapeutic Peptides with Scorpion Venom Origin. Jundishapur J Nat Pharm Prod. 2023;18(1):e134049. doi: https://doi.org/10.5812/jjnpp-134049

11
Jul
2022

An Update on Precision Pain Medicine: Na+ Channel Disorders

A. Sassan Sabouri

Sabouri AS. An Update on Precision Pain Medicine: Na+ Channel Disorders. J Cell Mol Anesth. 2022;7(3):e149680. doi: https://doi.org/10.22037/jcma.v7i3.38851

31
Jul
2014

Chain drugstores: Opportunities and Threats

Mehdi Mohammadzadeh,
Nazila Yousefi,
Hesam Sharifinia

Mohammadzadeh M, Yousefi N, Sharifinia H. Chain drugstores: Opportunities and Threats. Iran J Pharm Res. 2014;13(3):e125487. doi: https://doi.org/10.22037/ijpr.2014.1768

Download PDF221.09 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC